Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Animal ; 1(2): 283-92, 2007 Mar.
Article in English | MEDLINE | ID: mdl-22444294

ABSTRACT

Twenty-four low dry matter (DM) silages differing in fermentation quality were harvested at the same time from a crop that consisted mainly of timothy (Phleum pratense), and meadow fescue (Festuca pratensis). The silage samples were analysed by gas chromatography (GC) - mass spectrometry and gas chromatography - flame ionisation detection in order to determine and quantify volatiles present in silage. The voluntary intake of the 24 silages had been measured in a previous feeding trial with growing steers of Norwegian Red. Thirteen esters, five aldehydes, three alcohols, and one sulphide were identified and quantified. A total of 51 variables describing the chemical composition of the silages were included in a partial least-squares regression, and the relationship of silage fermentation quality to voluntary intake was elucidated. The importance of variables describing silage fermentation quality in relation to intake was judged from a best combination procedure, jack-knifing, and empirical correlations of the variables to intake. The GC-analysed compounds were mainly present in poorly fermented silages. However, compared with other explanatory chemical variables none of these compounds was of importance for the voluntary intake as evaluated by partial least-squares regression. A validated variance of 71% in silage DM intake was explained with the selected variables: total acids (TA), total volatile fatty acids (TVFA), lactic acid/total acid ratio and propionic acid. In this study extent (by the variable TA) and type of silage fermentation (by TVFA) influenced intake. Further, it is suggested that by restricting the fermentation in low DM grass silages the potential intake of silage DM is maximised.

2.
Article in English | MEDLINE | ID: mdl-16806871

ABSTRACT

Omega-3 fatty acids have a long history of use as dietary supplements and more recently for therapeutic applications as prescription pharmaceuticals. Achieving a high concentration is critical for developing convenient, practical therapeutic formulations. The objective of the study was to explore the uptake and effects of different concentrations of omega-3 acid ethyl esters. Three different omega-3 concentrations were investigated in a clinical study with 101 subjects. All participants were dosed for 14 days with 5.1g per day of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) ethyl esters provided in three concentrations: 62.5%, 80% and 85% of total fatty acids. Key endpoints of the study were serum phospholipids and standard fasting lipid panels at day 14. Although administered the same quantity of omega-3 fatty acids, the patients taking the more concentrated formulations had higher levels of EPA/DHA in serum phospholipids and greater reductions in serum triglyceride and VLDL cholesterol levels. Total and non-HDL cholesterol were significantly reduced from baseline with all three formulations. In conclusion the concentration of omega-3 fatty acids of the formulations studied had independent effects on the uptake and effect outcomes during short-term administration. Very high concentrations of omega-3 acid ethyl esters (80%) appear to have higher uptake and are more potent for reducing triglycerides (TGs) and VLDL-cholesterol than formulations with lower concentrations.


Subject(s)
Fatty Acids, Omega-3/pharmacokinetics , Adolescent , Adult , Biological Availability , Dietary Supplements , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/pharmacokinetics , Dose-Response Relationship, Drug , Double-Blind Method , Eicosapentaenoic Acid/administration & dosage , Eicosapentaenoic Acid/pharmacokinetics , Esters/administration & dosage , Esters/pharmacokinetics , Fatty Acids, Omega-3/administration & dosage , Humans , Lipids/analysis , Lipids/blood , Male , Middle Aged , Pharmacokinetics , Phospholipids/analysis , Phospholipids/blood
3.
Biochem J ; 222(2): 389-94, 1984 Sep 01.
Article in English | MEDLINE | ID: mdl-6433899

ABSTRACT

Phospholipase C (from Bacillus cereus) was used to study fresh and stored human platelets. Provided that the enzyme was inactivated before lipid extraction, no significant degradation of phospholipid in fresh cells was noted, even when platelets were activated or induced to change shape by ADP, collagen or thrombin. With platelets isolated from concentrates stored for transfusion for 4 days at 22 degrees C, membrane phospholipids were degraded by the enzyme to an extent depending on the pH in the platelet concentrate at day 4 of storage. The extent of phospholipid hydrolysis in platelets correlated well with the extent of release of lactate dehydrogenase during storage, with both being minimal for platelets from concentrates of final pH 6.5-6.9. Under non-lytic conditions, phosphatidylcholine was the phospholipid most degraded (40%), with no significant degradation of phosphatidylserine being detected. Storage does not seem to alter the distribution of phospholipids at the external leaflet of the plasma membrane.


Subject(s)
Blood Platelets/metabolism , Phospholipases/pharmacology , Type C Phospholipases/pharmacology , Bacillus cereus/enzymology , Blood Platelets/drug effects , Blood Preservation , Humans , Hydrogen-Ion Concentration , Hydrolysis , In Vitro Techniques , L-Lactate Dehydrogenase/blood , Membrane Lipids/blood , Phospholipids/blood , Time Factors
4.
Biochem J ; 207(1): 117-21, 1982 Oct 01.
Article in English | MEDLINE | ID: mdl-6817748

ABSTRACT

Phospholipid degradation by native phospholipase C from Bacillus cereus and enzyme forms where one or both of the Zn2+ prosthetic groups had been replaced with Co2+ was studied in human erythrocyte membranes (ghosts) and resuspended freeze-dried bovine brain myelin. The rate of total phospholipid degradation was 2-9-fold more rapid with erythrocytes than with myelin. With both membrane systems the activity decreased in the order ZnZn-enzyme greater than ZnCo-enzyme greater than CoCo-enzyme. For all three enzyme forms with either membrane system, phosphatidylethanolamine (or the ethanolamine-containing phosphoglycerides) and phosphatidylcholine were hydrolysed most rapidly and sphingomyelin least. The relative rate of sphingomyelin degradation was highest with the ZnCo-enzyme. In myelin at low ionic strength there seemed to be a core of phospholipid that was very resistant to degradation by native phospholipase C but which was much more accessible to the Co2+-substituted forms. It is suggested that ZnCo-phospholipase C has potential applications in membrane studies.


Subject(s)
Bacillus cereus/enzymology , Cobalt/pharmacology , Phospholipases/metabolism , Type C Phospholipases/metabolism , Animals , Cattle , Cell Membrane/metabolism , Erythrocyte Membrane/metabolism , Humans , Hydrolysis , In Vitro Techniques , Myelin Sheath/metabolism , Phospholipids/blood , Phospholipids/metabolism , Substrate Specificity , Zinc/pharmacology
5.
Biochem J ; 203(3): 799-801, 1982 Jun 01.
Article in English | MEDLINE | ID: mdl-6810875

ABSTRACT

The rate of phospholipid hydrolysis in erythrocyte ghosts by Bacillus cereus phospholipase C was markedly decreased by the presence of NaCl at concentrations between 25 and 200 mM. The inhibition seemed to be due to Cl- and was unaffected by the type of cation present. The larger univalent anions such as HCO3-, Br-, Cl-, NO3-, CNO- and I- seemed most effective, whereas the bivalent anion SO42- was relatively ineffective at 0.1 M, as were acetate and formate. Tris buffers at 0.1 M caused marked inhibition. With bovine brain myelin, phospholipid hydrolysis by phospholipase C was also much more strongly inhibited by I- and Cl- than by SO42- or acetate. NaCl inhibited the hydrolysis by the enzyme of the soluble substrate dihexanoylglycerophosphocholine, thereby suggesting that the inhibiton did not arise simply from substrate effects.


Subject(s)
Anions/pharmacology , Bacillus cereus/enzymology , Phospholipases/antagonists & inhibitors , Type C Phospholipases/antagonists & inhibitors , Erythrocyte Membrane/metabolism , Humans , Phospholipids/blood , Sodium Chloride/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL